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Identification of plasticity and 
interactions of a highly conserved 
motif within a picornavirus capsid 
precursor required for virus 
infectivity
Thea Kristensen1 & Graham J. Belsham1,2
The picornavirus family includes poliovirus (PV) (genus: enterovirus), human rhinoviruses (enterovirus) 
and foot-and-mouth disease virus (FMDV) (aphthovirus). These are responsible for important human 
and animal health concerns worldwide including poliomyelitis, the common cold and foot-and-mouth 
disease (FMD) respectively. In picornavirus particles, the positive-sense RNA genome (ca. 7–9 kb) is 
packaged within a protein shell (capsid) usually consisting of three surface exposed proteins, VP1, VP2 
and VP3 plus the internal VP4, which are generated following cleavage of the capsid precursor by a 
virus-encoded protease. We have previously identified a motif near the C-terminus of FMDV VP1 that 
is required for capsid precursor processing. This motif is highly conserved among other picornaviruses, 
and is also likely to be important for their capsid precursor processing. We have now determined 
the plasticity of residues within this motif for virus infectivity and found an important interaction 
between FMDV residue VP1 R188 within this conserved motif and residue W129 in VP2 that is adjacent 
in the virus capsid. The FMDV (VP1 R188A) mutant virus has only been rescued with the secondary 
substitution VP2 W129R. This additional change compensates for the defect resulting from the VP1 
R188A substitution and restored both capsid precursor processing and virus viability.
Picornavirus RNA genomes include a single, large, open reading frame, ca. 6000–7000 nt long, encoding a poly-
protein that is co- and post-translationally processed to multiple precursors and then mature virus proteins1. 
Three or four primary products are made, namely the Leader protein (in many picornaviruses), the capsid pre-
cursor (P1 or P1-2A) and precursors of the non-structural proteins P2 and P3, (Fig. 1a). The structural and 
non-structural protein precursors rapidly separate. In cardio- and aphthoviruses, breakage of the polypeptide 
chain at the 2A/2B junction occurs during translation2,3. The 2A remains part of the capsid precursor as P1-2A 
until removed by the 3C protease (3Cpro), (Fig. 1a,c). In enteroviruses, the 2A protease cleaves the VP1/2A junc-
tion to release P14,5.
The junction between P2 and P3 plus their internal protein junctions are cleaved by 3Cpro, to produce the vari-
ous non-structural proteins. In aphtho- and cardioviruses, the 3Cpro also processes the P1-2A precursor into VP0, 
VP3 and VP1 plus 2A6,7. However, the enterovirus P1 precursor is cleaved by 3CD protease (3CDpro)8,9. Following 
cleavage of the capsid precursor, VP0, VP3 and VP1 remain together as a protomer, (Fig. 1c). Five protomers 
combine to form a pentamer and 12 pentamers assemble to make virus particles, (Fig. 1c). In most picornavi-
ruses, VP0 is cleaved to VP2 and VP4 during particle assembly.
Protein functionality is highly dependent on correct folding. Evidence suggests that cellular chaperones, 
including different heat shock proteins (e.g. Hsp90), are required for assembly of various picornaviruses10,11. 
Hsp90 protects the PV capsid precursor from degradation by proteasomes, which remove misfolded proteins10.
We showed previously that inhibiting the cleavage of individual junctions within the FMDV P1-2A capsid 
precursor, did not affect cleavage of other junctions within the precursor12. However, we have also identified a 
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short motif within the C-terminus of FMDV VP1 which is critical for processing of the entire capsid precursor13. 
This motif, YCPRP (residues 185–189), is highly conserved amongst FMDVs of all seven serotypes, even though 
VP1 is the most variable FMDV protein with only 26% of its residues being invariant14–16. The motif is also highly 
conserved in other picornaviruses (FCPRP in cardioviruses and WCPRP in enteroviruses), (Fig. 1a,b). In cells 
expressing the FMDV P1-2A precursor with 3Cpro, we showed that substituting single residues within this motif 
severely inhibited cleavage at the VP0/VP3 and the VP3/VP1 junctions. These junctions are far away from the 
modified motif in the linear sequence suggesting these changes affect the overall structure of the capsid precur-
sor13. Earlier studies had shown that removal of the VP1 C-terminus from the capsid precursor of both PV and 
FMDV, which deleted this conserved motif, resulted in truncated precursors that could not be processed in vitro 
whilst retaining the unmodified VP0/VP3 and VP3/VP1 junctions17,18. Thus, it seems that the conserved motif is 
required for capsid precursor processing in multiple members of the picornavirus family.
We have now defined the plasticity of this motif within FMDV and identified adaptation, during mutant virus 
rescue, which revealed interaction between this motif and the adjacent VP2 molecule.
Results
Production of FMDVs with modifications in the highly conserved YCPRP motif. We have now 
investigated the effect of modifying the conserved YCPRP motif within the context of infectious FMDVs. 
Modifications were introduced into a full-length infectious cDNA based on the O1 Kaufbeuren FMDV but with 
the coding region for VP2-VP3-VP1-2A derived from the A22 Iraq virus (as used previously12,13,19,20). The plas-
mids were named according to their modifications: FMDV (VP1 ∆185–190), FMDV (VP1 Y185A), FMDV (VP1 
C186A), FMDV (VP1 P187A), FMDV (VP1 R188A) and FMDV (VP1 P189A). In order to rescue the viruses, 
full-length RNA transcripts were produced in vitro, using T7 RNA polymerase, and introduced into BHK cells by 
electroporation. Samples from the harvested cells were added to fresh cells (passage 1). Already at this first pas-
sage, the FMDV (wt) and the mutants FMDV (VP1 C186A) and FMDV (VP1 189A) produced CPE in the cells 
(Table 1, as described previously13). At the second passage, the mutant FMDV (VP1 R188A) also produced some 
CPE and at the third passage, this mutant produced full CPE. None of the other mutant transcripts (FMDV (VP1 
∆185–190), FMDV (VP1 Y185A) or FMDV (VP1 P187A)) produced CPE even after four passages (Table 1).
RNA was extracted from virus harvests when CPE had been observed and RT-PCR was performed to amplify 
the P1-2A coding region within multiple, overlapping, amplicons that were sequenced. The wt virus sequence was 
unchanged and the rescued FMDV (VP1 C186A) and FMDV (VP1 P189A) had retained their encoded amino 
acid substitutions. For both of these mutants, no secondary mutations were observed within the P1-2A coding 
sequence. However, the rescued FMDV (VP1 R188A) mutant had acquired two secondary mutations. These 
encoded the substitutions VP2 W129R and VP3 E70G (Table 1) that are located far away (495 or 336 residues, 
respectively) from the conserved YCPRP motif in the linear amino acid sequence. This mutant virus, with the 
additional substitutions, is termed FMDV (VP1 R188A*) to indicate that it has additional changes. The delayed 
Figure 1. Picornavirus capsid assembly. (a) The genome organization of FMDV is shown. The viral RNA 
encodes a large polyprotein that is processed to yield precursors and finally mature products. The FMDV 
capsid protein precursor (P1-2A) includes the conserved YCPRP motif near the C-terminus of VP1. The 
Leader protease (Lpro) cleaves itself from the P1-2A precursor. Ribosomal skipping at the C-terminus of 2A is 
marked with an arrow. The 3Cpro (red) is responsible for cleavage of all other junctions. (b) A logoplot showing 
variation in this conserved motif amongst a collection of picornavirus sequences (from http://www.virology.
wisc.edu/acp/Aligns/aligns/picorna.p1) was generated using https://weblogo.berkeley.edu. (c) The pathway of 
capsid assembly is shown from the processing of the capsid precursor P1-2A by the 3Cpro, to the formation of 
protomers, the assembly of pentamers and finally the generation of complete capsids. The cleavage of VP0 to 
VP4 and VP2 occurs during the formation of virus particles. The structures of the pentamer and virus particle 
are from PDB 4GH421.
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appearance of CPE during the rescue of this mutant is consistent with the apparent need for virus adaptation, with 
the acquisition of additional compensatory substitutions, to allow efficient virus growth.
Identification of plasticity within the YCPRP motif. To investigate which amino acid changes can be 
tolerated within the conserved YCPRP motif of the virus, the codons for each of its 5 amino acids were individ-
ually changed to the sequence NNN (corresponding to all four nucleotides at each position), to produce every 
possible codon. It should be noted that the template used for mutagenesis, in each case, was a mutant that failed 
to yield infectious virus at first passage. Plasmid pools, containing the degenerate codons encoding each residue, 
were produced and sequenced (as a pool) to demonstrate the heterogeneity at the modified codons (Fig. 2). RNA 
transcripts were then produced and introduced into BHK cells, as above. All of the mutant transcripts produced 
some CPE at the first passage and full CPE at the second passage, thus the mutagenesis had enhanced infectivity.
No secondary mutations were observed in the P1-2A coding sequence of any of the rescued NNN- mutant 
viruses outside of the targeted codon. For FMDV (VP1 Y185NNN) and FMDV (VP1 R188NNN) unique 
sequence was present in the rescued virus pool at the modified codon (Fig. 2). However, sequence heteroge-
neity was observed at the other modified codons, i.e. FMDV (VP1 C186NNN), FMDV (VP1 P187NNN) and 
FMDV (VP1 P189NNN) (Fig. 2). To identify these codons individually, amplicons containing the coding region 
for VP1-2A were cloned and plasmids from >10 individual colonies were sequenced. Each colony contains the 
sequence corresponding to the VP1-2A coding region from a single FMDV RNA genome. Sequences from the 
plasmid pool and each of the various clones from the FMDV cDNA were determined (Fig. 2) thus, this analysis 
provided an overview of the heterogeneity of the virus population and indicated which amino acids could be tol-
erated, within infectious virus, at each position (Fig. 2). Strikingly, there was a very strong selection for the tyros-
ine (Y) residue at position 185 with only the codon TAC, corresponding to the wt sequence, being observed at this 
site. In contrast, at residue 186, which in the wt sequence is a cysteine (C), a marked diversity of amino acid sub-
stitutions was apparent. Alanine (A), encoded by two different codons, valine (V) and serine (S) were observed 
at this site (Fig. 2). None of the rescued FMDV genomes derived from the FMDV (VP1 C186NNN) mutant 
encoded the wt C at this position. The identity of this residue appears to be relatively unconstrained, indeed, it 
was previously shown to be of little importance for the processing of the capsid precursor13. Furthermore, this 
residue shows the greatest diversity among the different picornaviruses (Fig. 1b). However, the observed residues 
encoded by the rescued FMDV (VP1 C186NNN) mutants all have a neutral charge and are relatively small. At 
residue 187, the rescued viruses only encoded a proline (P), as in the wt sequence, however, two synonymous 
codons (CCA and CCG) were observed, in contrast to the wt codon, (CCC). From the FMDV (VP1 R188NNN) 
mutant, only an arginine (R) residue, as present in the wt virus, was found. However, the codon (CGT) was differ-
ent from the wt sequence (AGA) (Fig. 2). There was also strong selection for P at residue 189. Two synonymous 
codons (CCC and CCT) were observed, in contrast to the wt codon (CCA) (Fig. 2).
The strict requirement for the FMDV (VP1 Y185) and FMDV (VP1 R188) were fully consistent with our 
earlier studies where we showed that neither the P1-2A (VP1 Y185A) nor the P1-2A (VP1 R188A) capsid precur-
sors could be processed13 and with the failure to rescue FMDV (VP1 Y185A) and FMDV (VP1 R188A) (without 
RNA transcript
CPE at 
Psg. 1
CPE at 
Psg. 2
CPE at 
Psg. 3
CPE at 
Psg. 4 Changes in rescued virus Comment
FMDV (VP1 ∆185–189) − − − −
FMDV (VP1 Y185A) − − − −
FMDV (VP1 C186A) +++ +++ +++ n.d. −
FMDV (VP1 P187A) − − − −
FMDV (VP1 R188A) − + +++ +++ VP2 W129R + VP3 E70G FMDV (VP1 R188A)*
FMDV (VP1 P189A) +++ +++ +++ n.d. −
FMDV (VP2 W129R) +++ +++ +++ n.d. −
FMDV (VP3 E70G) +++ +++ +++ n.d. −
FMDV (VP1 Y185A) repetition − − − −
FMDV (VP1 Y185A + VP2 W129R) − − − −
FMDV (VP1 Y185A + VP3 E70G) − − − −
FMDV (VP1 R188A) repetition − + +++ +++ VP2 W129R + VP2 A74G‡ FMDV (VP1 R188A)**
FMDV (VP1 R188A + VP2 W129R) +++ +++ +++ n.d. −
FMDV (VP1 R188A + VP3 E70G) − − − −
FMDV (wt) +++ +++ +++ n.d. −
None − − − −
Table 1. The indicated RNA transcripts were introduced into BHK cells using electroporation. After 24 hr, 
the cells and medium were frozen and an aliquot of 800 µl was added to fresh cells (passage 1). After CPE 
developed, or 48 hr (whichever was sooner), the procedure was repeated for passages 2, 3 and 4, however in 
cases of full CPE the virus aliquot for the next passage was reduced to 200 µl. Full CPE is indicated as +++, 
some CPE is indicated as+, while the absence of CPE is indicated as -, n.d. means not determined and Psg. 
indicates the passage number. “Repetition” indicates that a new synthesis and introduction of the RNA into 
cells was performed. ‡: In 12/15 clones sequenced the VP2 A74G change was present, while in 1/15 clones the 
substitution F75L was also present, the VP2 W129R change alone was present in 3/15 clones.
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adaptations), (Table 1). Thus, residues VP1 Y185 and R188 are of high importance both for the processing of 
the FMDV capsid precursor and for virus viability. There was also a strong selection for both the wt VP1 P187 
and VP1 P189 residues. These residues are not critical for the processing of the capsid precursor in the transient 
expression assay13. However, the FMDV (VP1 P187A) mutant could not be rescued (Table 1). In contrast, the 
FMDV (VP1 P189A) mutant was viable, indicating that alternative residues can be tolerated (see16). Thus, from 
all the possible versions of the motif (when changing one residue at a time), all the rescued FMDVs encoded the 
sequence YxPRP (where x can be at least C, A, V and S) consistent with the high degree of conservation of this 
motif among FMDVs. The YxPRP residues are very conserved among other picornaviruses (Fig. 1b) and thus it 
seems very likely that this motif plays a similar, important role in these other viruses.
Rescue of mutant FMDVs containing secondary substitutions. Two secondary mutations were 
observed in the rescued FMDV (VP1 R188A*) mutant, namely VP2 W129R and VP3 E70G. Our earlier studies13 
had shown that the VP1 R188A substitution in the FMDV capsid precursor P1-2A, when expressed in a transient 
expression assay, severely inhibited processing of the junctions between the structural proteins. Thus, since the 
FMDV (VP1 R188A*) mutant was clearly viable, we expected that one or both of the observed secondary muta-
tions would have a positive effect on the cleavage of the junctions within the capsid precursor. To investigate the 
effect of these secondary mutations, each was introduced individually into the full-length FMDV (wt) cDNA 
and called FMDV (VP2 W129R) and FMDV (VP3 E70G) respectively. Furthermore, to determine how these 
two substitutions affected the properties of the non-processable mutant with the VP1 R188A substitution, the 
changes were also introduced into the quasi-infectious FMDV (VP1 R188A) cDNA clone. These plasmids were 
called FMDV (VP1 R188A + VP2 W129R) and FMDV (VP1 R188A + VP3 E70G). To analyze whether one of 
Figure 2. The plasticity of the YCPRP motif within infectious FMDV. Mutagenesis was performed on 
defective mutant full-length FMDV cDNA templates (see text) to modify the codon for each residue within 
the YCPRP individually to all possible codons (NNN). The pools of plasmids obtained were sequenced and 
the heterogeneity in each pool is shown. RNA transcripts were prepared from each mutant pool separately 
and introduced into cells to recover infectious virus. CPE was observed at passage 1 (c.f. the mutant template) 
in each case and then amplified through 2 passages in total. RNA was extracted from these rescued viruses, 
converted to cDNA and sequenced throughout the P1-2A coding region. No secondary substitutions were 
observed and heterogeneity was only observed within the sequence encoding the conserved motif in VP1. 
From each cDNA pool, a cDNA fragment, encoding VP1-2A, was amplified and inserted into a TOPO vector 
and individual clones (10–33) were sequenced. Representatives of the distinct individual sequences are 
shown together with the encoded amino acid sequence. The number and frequency (%) of each codon within 
the individual clones analyzed is shown. Note, within the rescued viruses, the presence of 4 distinct codons 
(encoding 3 different amino acids) at the position of C186, whereas only the wt TAC sequence (encoding Y) was 
present at the codon for residue 185. At the codons for residues P187, R188 and P189, only viruses with the wt 
amino acid were rescued but alternate (non-wt) codons were present.
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these secondary mutations also affected the viability of the FMDV (VP1 Y185A) mutant, each of the changes 
was also introduced into the non-infectious FMDV (VP1 Y185A) cDNA clone. These plasmids are referred to as 
FMDV (VP1 Y185A + VP2 W129R) and FMDV (VP1 Y185A + VP3 E70G). The rescue of viruses from FMDV 
(VP1 Y185A) and the FMDV (VP1 R188A) plasmids was repeated, in parallel, to confirm that no virus could be 
rescued from the FMDV (VP1 Y185A) mutant and to determine whether we could again rescue mutant virus 
from the quasi-infectious FMDV (VP1 R188A) mutant.
Following introduction of RNA transcripts into cells, the FMDV (VP2 W129R), FMDV (VP3 E70G) and the 
FMDV (VP1 R188A + VP2 W129R) mutants, all produced full CPE at the first passage (Table 1). As observed ini-
tially, the FMDV (VP1 R188A) only generated some signs of CPE at the second passage and full CPE was appar-
ent at the third passage. This independently rescued virus is referred to as FMDV (VP1 R188A**). In contrast, no 
CPE was observed for the FMDV (VP1 R188A + VP3 E70G) mutant after four passages, (Table 1). Similarly, the 
attempts to rescue virus from the FMDV (VP1 Y185A), the FMDV (VP1 Y185A + VP2 W129R) and the FMDV 
(VP1 Y185A + VP3 E70G) transcripts were each unsuccessful since no CPE was seen in any of the four passages, 
(Table 1). Thus, the VP2 W129R substitution was able to compensate for the deleterious effect of the VP1 R188A 
modification on virus infectivity but could not compensate for the effect of the VP1 Y185A change.
To characterize the rescued viruses, RNA was isolated from cells displaying CPE and RT-PCR was performed 
to amplify the P1-2A coding region in multiple, overlapping amplicons, as above, and the sequence correspond-
ing to the complete P1-2A precursor was determined. The rescued FMDV (VP2 W129R) and FMDV (VP3 E70G) 
had each retained their encoded amino acid substitutions and no secondary mutations were present within 
the P1-2A coding sequence, thus these substitutions did not have any significant deleterious effect on the wt 
virus. The FMDV (VP1 R188A + VP2 W129R) had also retained both substitutions and no additional sequence 
changes were observed within the P1-2A coding region. Sequencing of the independently rescued FMDV (VP1 
R188A**) mutant, revealed that this virus had exactly the same secondary substitution (VP2 W129R) as observed 
in the FMDV (VP1 R188A*) mutant (Table 1). However, the VP3 E70G mutation, which was observed in the 
FMDV (VP1 R188A*) mutant, was not present in the FMDV (VP1 R188A**). Instead, another substitution was 
observed in VP2, namely A74G. This substitution was present in the majority of the virus (12/15 clones analyzed) 
whereas the rest of the viruses still had the wt sequence at this specific site (3/15). Furthermore, an additional 
substitution, VP2 F75L, was observed in just one of the clones obtained from the viral cDNA that also encoded 
the VP2 A74G substitution.
To investigate whether the secondary mutations VP2 W129R and VP3 E70G had any effect on virus growth, 
the virus yield from BHK cells infected with FMDV (VP2 W129R), FMDV (VP3 E70G) and the FMDV (VP1 
R188A + VP2 W129R) mutants were determined in parallel with FMDV (wt). No major differences in their 
growth kinetics were observed (Supplementary Fig. S1).
The effect of the secondary substitutions on P1-2A processing by 3Cpro. We also analyzed the 
effect of the two secondary substitutions, VP2 W129R and VP3 E70G, on the processing of the capsid precur-
sor by 3Cpro, both of these changes were introduced individually into the P1-2A (VP1 R188A) plasmids. These 
are referred to as P1-2A (VP1 R188A + VP2 W129R) and P1-2A (VP1 R188A + VP3 E70G). These plasmids 
together with the P1-2A (wt) and the P1-2A (VP1 R188A) were expressed in a transient expression assay either 
in the absence or presence of 3Cpro, as described earlier13. As expected, when the wt plasmid was assayed alone it 
generated a product (P1-2A) of approximately 85 kDa (Fig. 3, lane 1). However, when co-expressed with 3Cpro, the 
P1-2A (wt) product was processed and yielded a product of approximately 37 kDa (corresponding to VP0) (Fig. 3, 
lane 2). The P1-2A (VP1 R188A) and the P1-2A (VP1 R188A + VP3 E70G) both generated products of approx-
imately 85 kDa corresponding to the capsid precursor in the absence of 3Cpro (Fig. 3, lanes 3 and 7). However, 
these mutants were highly resistant to cleavage in the presence of 3Cpro (Fig. 3, lanes 4 and 8). The P1-2A (VP1 
R188A + VP2 W129R) mutant also made the capsid precursor when expressed alone (Fig. 3, lane 5) but, in 
contrast to these other mutants, in the presence of the 3Cpro, a product corresponding to VP0 was also detected 
indicating that processing of the capsid precursor had occurred (Fig. 3, lane 6). It should be noted, however, that 
the production of VP0 from this mutant P1-2A appeared less efficient than from the processing of the wt capsid 
precursor (Fig. 3, lanes 2 and 6).
Discussion
Recently, we showed that modifications of a short conserved motif (YCPRP) near the C-terminus of FMDV VP1, 
can prevent processing of the capsid precursor P1-2A at distal sites13. The VP0/VP3 and the VP3/VP1 cleavage 
sites are located far away (ca. 400 and almost 200 residues, respectively) from the modified motif in the linear 
sequence. Thus, it seems likely that the overall protein conformation has changed following modification of this 
motif consistent with the need for chaperones for capsid assembly10,11. The motif is very highly conserved among 
FMDV strains13,16 and is also well conserved among other members of the picornavirus family13. We have now 
explored, in detail, the impact of modifications within the conserved motif on virus infectivity. Deletion of the 
whole YCPRP motif or just the VP1 Y185A substitution blocked the production of viable virus. This was con-
sistent with our previous study13, where we showed that the P1-2A precursors with these modifications, or with 
the VP1 R188A substitution, could not be processed by 3Cpro. However, interestingly, the FMDV (VP1 R188A) 
mutant produced CPE during virus rescue that was delayed compared to the wt. When the rescued virus, termed 
FMDV (VP1 R188A*), was sequenced it was found that it had adapted and acquired two secondary substitutions, 
namely VP2 W129R and VP3 E70G. Repeating the electroporation and passage of the FMDV (VP1 R188A) again 
resulted in delayed CPE and sequencing of this rescued FMDV (VP1 R188A**) revealed that it had also acquired 
the substitution VP2 W129R. Furthermore, a major proportion (12/15 genomes analyzed) of this rescued FMDV 
(VP1 R188A**) had also acquired the secondary substitution VP2 A74G, and one of these also had the VP2 F75L 
substitution. These secondary mutations are located far away from the modified motif in the linear sequence. 
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However, examination of the three-dimensional structure of FMDV A2221 revealed that VP1 R188 (within the 
conserved YCPRP motif) and VP2 W129 are located adjacent to each other at the interface between VP1 and 
VP2, (Fig. 4). The residues VP2 A74, VP2 F75L and VP3 E70 are located further away from the conserved motif 
in the virus structure, (Supplementary Fig. S2). Thus, it seems that there is an important interaction between resi-
dues VP1 R188 and VP2 W129. This interaction, and maybe the other substituted residues, may also be important 
for the folding of the capsid precursor (P1-2A). Surprisingly, the FMDV (VP1 R188A + VP3 E70G) did not yield 
any viable virus; it seems the VP2 W129R adaptation did not occur. The VP2 W129 residue is not conserved in 
other picornaviruses or even among other FMDV serotypes. However, immediately upstream of the VP2 W129 
residue, there is a sequence QFNGGCLLVAMVPE (residues 115–128), which is very conserved among FMDVs 
(Fig. 5). Furthermore, this sequence is also highly conserved among other picornaviruses (Fig. 5). In the mature 
virus capsid, this sequence forms a beta strand that lies adjacent to the VP1 beta strand that ends in the conserved 
YCPRP motif. Substituting the R in the YCPRP motif, resulted in selection of mutant viruses with a secondary 
change VP2 W129R in two independently rescued viruses. Thus, it seems that there is a need for at least one 
positively charged amino acid at one of these locations. Among different FMDVs, the residue VP2 129 can be 
W, L or M, whereas in cardioviruses and polioviruses the corresponding residue is Y, F or M (Fig. 5). Thus, it 
seems that aromatic/hydrophobic residues are strongly selected at this site. The FMDV VP2 W129R substitution 
observed in the rescued FMDV (VP1 R188A*) and FMDV (VP1 R188A**) mutants is therefore unusual, in that 
the positively charged R residue is not normally observed at this position. This substitution is, most likely, selected 
due to the loss of the positive charge in the VP1 R188A mutant. It is, however, noteworthy that the VP2 W129R 
substitution alone was tolerated in infectious FMDV without any additional substitutions.
The FMDV (VP1 R188A + VP2 W129R) mutant generated CPE at the first passage and did not display a 
major defect in growth rate compared to the FMDV (wt) (Supplementary Fig. S1). This indicated that the VP2 
W129R substitution is able to compensate efficiently for the deleterious effect of the VP1 R188A substitution in 
relation to virus viability. However, from the analysis of P1-2A processing (Fig. 3), it appears that the VP2 W129R 
substitution does not fully restore the processing efficiency of the mutant capsid precursor. In the presence of 
low levels of 3Cpro, VP0 was generated less efficiently from the P1-2A (VP1 R188A + VP2 W129R) mutant than 
from the P1-2A (wt), (Fig. 3, lanes 2 and 6). However, it should be noted that the FMDV A22 Iraq strain, as used 
in this study, generates a lot of empty capsids within infected cells12,20,22, thus it seems that the virus produces an 
excess of capsid proteins, which are not required for virus production. Furthermore, we have shown previously 
that slowing processing at the VP0/VP3 junction, did not affect the growth rate of a mutant FMDV A22 Iraq with 
this defect12. It is noteworthy that in the transient expression assay, there is a fixed ratio for the level of the P1-2A 
precursor and the 3Cpro. In contrast, within cells infected with FMDV, there is, overtime, an increasing level of the 
3Cpro compared to the P1-2A precursor substrate, as the precursor is processed without loss of 3Cpro. This may 
allow efficient processing of a slightly sub-optimal substrate within infected cells.
Interestingly, the FMDV (VP1 Y185A + VP2 W129R), FMDV (Y185A + VP3 E70G) and the FMDV (VP1 
R188A + VP3 E70G) mutants could not be rescued even after four passages (Table 1). This indicates that the VP2 
W129R substitution was unable to compensate for the deleterious VP1 Y185A substitution. This likely reflects 
that there is no direct interaction between VP1 Y185 and VP2 W129, c.f. the interaction between the VP1 R188 
Figure 3. A second site substitution within VP2 compensates for the deleterious effect of the VP1 R188A 
modification in the FMDV P1-2A capsid precursor. Plasmids encoding wt or mutant forms of the FMDV 
P1-2A (as indicated) were expressed alone (odd numbered lanes) or with the FMDV 3Cpro (even numbered 
lanes) within BHK cells, as described in Methods section. Cell lysates were analyzed by SDS-PAGE and 
immunoblotting using guinea pig anti-FMDV O-Man antisera. Bound antibodies were visualized using the 
anti-guinea pig HRP-conjugated secondary antibodies and a chemiluminescence detection kit. The unprocessed 
P1-2A precursor and the VP0 processing product are indicated. Note the enhanced processing of the P1-2A 
(VP1 R188A) mutant in the presence of the substitution VP2 (W129R).
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and VP2 W129 residues. In conclusion, the analyses we have presented here and previously13, demonstrate the 
critical importance of the YCPRP motif near the C-terminus of VP1 in FMDV for P1-2A processing and virus 
viability. This is consistent with its high conservation among FMDVs and across other genera of the picornavirus 
family (Fig. 1b). The identification of a specific compensatory substitution (VP2 W129R) in the presence of the 
VP1 R188A substitution suggests an important interaction between these residues in the mature virus particle 
and also potentially during the process of capsid precursor assembly. As the motif is highly conserved among dif-
ferent picornaviruses13,16, the results obtained here with FMDV are very likely to be applicable to other members 
of this important virus family.
Methods
Plasmid constructions. Plasmid pO1K/A22 contains a full-length FMDV cDNA with the A22 Iraq capsid 
coding sequence within an FMDV O1K backbone12,19,20 and is referred to here as FMDV (wt). Seven individual 
modifications to the coding sequence for VP1 were made as described previously13 using this plasmid as tem-
plate for the mutagenesis. The products were called: FMDV (VP1 Δ185-189), FMDV (VP1 Y185A), FMDV 
(VP1 C186A), FMDV (VP1 P187A), FMDV (VP1 188A) and FMDV (VP1 189A). Additional modifications 
were individually introduced into FMDV (wt), FMDV (VP1 R188A) and FMDV (VP1 Y185A) backgrounds, 
as required. These new constructs were named FMDV (VP2 W129R), FMDV (VP3 E70G), FMDV (VP1 
R188A + VP2 W129R), FMDV (VP1 R188A + VP3 E70G), FMDV (VP1 Y185A + VP2 W129R) and FMDV 
(VP1 Y185A + VP3 E70G) according to the capsid protein and residues changed. To investigate the effect of each 
of the secondary mutation observed in the FMDV (VP1 R188A*) mutant on cleavage of the capsid precursor, 
these mutations were introduced into a plasmid only containing the coding sequence of the capsid precursor as 
described earlier12,13. The resultant plasmids were named according to their modifications, P1-2A (VP1 R188A), 
P1-2A (VP1 R188A + VP2 W129R) and P1-2A (VP1 R188A + VP3 E70G). All primers for generating the differ-
ent constructs are listed in Supplementary Table S1.
Identification of YCPRP motif plasticity within infectious FMDV. To investigate which amino acids 
can be tolerated in place of the VP1 residues Y185, C186, P187, R188 and P189, modifications using primers 
with all four nucleotides at each position of the codons, (i.e. NNN) were introduced. Mutant plasmids that 
did not readily generate infectious virus were used as the templates for the mutagenesis using primers listed 
in Supplementary Table S1, hence rescued viruses should predominantly be obtained from modified cDNAs. 
Plasmid FMDV (VP1 Y185A) was used to make the mutant pools FMDV (VP1 Y185NNN) and FMDV (VP1 
C186NNN) while FMDV (VP1 P187A) was used for FMDV (VP1 P187NNN) and FMDV (VP1 R188A) was used 
for FMDV (VP1 R188NNN) plus FMDV (VP1 P189NNN). After transformation of E. coli, all colonies generated 
per mutant were pooled and amplified. The plasmid DNA pools (potentially containing all codons at each modi-
fied site) were purified and sequenced to confirm the heterogeneity at each modified codon, (Fig. 2).
Rescue of modified FMDVs. Plasmids, containing the full-length (wt or mutant) FMDV cDNAs were lin-
earized by digestion with HpaI, purified and transcribed in vitro using the MEGAscript® T7 Transcription Kit 
(Thermo Fisher Scientific), as described by the manufacturer. An aliquot of each RNA was checked for integrity, 
DNase treated and introduced into BHK cells (in PBS) by electroporation23. The cells, were transferred to Eagle’s 
medium (8 ml) with 5% calf serum, and incubated with 5% CO2 at 37 °C. After 24 h, the cells and medium were 
harvested by freeze/thawing and an aliquot passaged onto fresh BHK cells. The procedure was repeated for subse-
quent passages. Up to four passages were performed for each RNA transcript, incubations were continued in each 
passage until complete CPE was observed or for 48 h at most. RNA was isolated from cells that displayed CPE (i.e. 
containing infectious virus) using the RNeasy Mini Kit (Qiagen). The RNA was reverse transcribed using random 
primers. For each reaction, a negative control, lacking the reverse transcriptase (-RT), was included to verify that 
the PCR products were produced from viral RNA and not from residual plasmid template.
Figure 4. Location of residues VP1 R188 (within the conserved motif) and VP2 W129 in the virus structure. 
(a) The structure of a pentamer from within the FMDV A22 Iraq capsid is shown (from PDB 4GH421). (b) 
An expanded view of a single protomer viewed (from a different angle) is shown and the box marks a further 
expanded view, as shown in (c) with the residues VP1 R188 and VP2 W129 at the interface between VP1 and 
VP2 indicated. VP1 is shown in dark blue and VP2 is in light blue.
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Sequencing of rescued FMDVs. The virus-derived cDNA was used to amplify four overlapping fragments 
(ca.1000 bp each), using primers listed in Supplementary Table S2, corresponding to the entire P1-2A coding 
region. The amplicons were purified and sequenced, as above, using primers listed in Supplementary Table S2. 
Figure 5. Conservation of VP2 sequences among picornaviruses. The amino acid sequence upstream of residue 
W129 within VP2 of FMDV (marked with an ↓) is highly conserved among other FMDVs and also among 
other picornaviruses. Amino acids that are identical among most FMDVs and are also conserved in other virus 
genera are highlighted in yellow. Non-conserved residues that have similar properties to the conserved residues 
are highlighted in other colours (see key). Residues that differ from FMDV but are highly conserved within 
particular virus genera or species are also marked. The selected viruses were derived from alignments available 
at (http://www.virology.wisc.edu/acp/Aligns/aligns/picorna.p1).
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Heterogeneity was observed in the FMDV (VP1 R188A**) mutant and in most of the FMDV NNN mutants. 
For all of the FMDV NNN mutants, the VP1-2A coding region was amplified using primer 14TPN9_Fw and 
14TPN14_Rev (Supplementary Table S2) while for the FMDV (VP1 R188A**) mutant, primers 14TPN5_Fw and 
14TPN8_Rev were used, (Supplementary Table S2). The products were cloned using TOPO XL or XL2 (Thermo 
Fisher Scientific). From individual colonies (10 initially), plasmid DNA was purified and sequenced using the 
same two primers. Sequences were analyzed using Geneious 9.0.2 (Biomatters).
Virus titrations and growth rate assays. Rescued viruses were titrated in BHK cells as described previ-
ously12. To determine virus growth rates, BHK cells were infected with the wt or selected mutant FMDVs using 
a MOI = 0.01, essentially as described previously12. The cells were incubated prior to harvesting at 0, 3, 6, 10 and 
24 h p.i. and then frozen; virus harvests were titrated in fresh BHK cells and the virus yields (as TCID50/ml) were 
calculated.
Transient expression assay and western blot. Transient expression assays and immunoblotting were 
performed as described previously13. For the blots, PBS containing 5% bovine serum albumin (BSA) and 0.1% 
Tween20 was used as blocking buffer and the guinea pig anti-FMDV O-Manisa antisera was used as primary 
antibody.
Data Availability
The authors confirm that the data supporting the findings of this study are available within the article and its 
supplementary materials.
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